Investment
Features
FeesSafety
Academy
More
Pluang+

Compare W W Grainger Inc (GWW) vs Eli Lilly And Co (LLY) Price & Performance

W W Grainger IncTrade
Eli Lilly And CoTrade

Price performance (Past 24H)

Key statistics

W W Grainger Inc vs Eli Lilly And Co — how do they compare? W W Grainger Inc trades at $1,388.97 (market cap $64.75B), while Eli Lilly And Co trades at $1,176.19 (market cap $1.03T). The key difference: Eli Lilly And Co is far larger — about 15.9× W W Grainger Inc's market cap, and W W Grainger Inc pays the higher dividend (0.68%). Which is the better fit depends on your goals.

GWWLLY
Market Cap
$64.75B$1.03T
Sector
TechnologyHealth
52-Week High
$1.39K$1.24K
52-Week Low
$918.18$625.65
Enterprise Value
$66.84B$1.07T
Dividend Yield
0.68%0.6%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

W W Grainger Inc

No Aura AI signal available yet.

Eli Lilly And Co

Eli Lilly (LLY) trades at $1,176.75, up 1.95% on the day, with strong fundamentals including a 31.66% net margin and consistent earnings beats. The stock shows a bearish technical signal near resistance at $1,177, while recent news highlights the $2.8 billion acquisition of AtaiBeckley to expand its mental health pipeline. Operating cash flow surged to $16.81 billion in 2025, supporting growth initiatives in obesity and Alzheimer's treatments.

Outlook remains positive with a $1.38K analyst price target and 73% buy ratings, but risks include competitive pressure in obesity drugs and high valuation multiples. Revenue growth of 65% in 2025 underscores momentum, though debt levels and acquisition integration pose challenges for sustained outperformance.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About W W Grainger Inc

Grainger is a leading broad-line distributor of maintenance, repair, and operating (MRO) products. It serves millions of customers worldwide through an integrated network of branches and digital platforms.

Read more on GWW

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

Read more on LLY